BRENTWOOD, Tenn. / Aug 28, 2024 / Business Wire / Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced the Company will participate in the Morgan Stanley 22nd Annual Global Healthcare Conference being held September 4-6, 2024, in New York, NY.
Ardent Health President and Chief Executive Officer Marty Bonick and Chief Financial Officer Alfred Lumsdaine will take part in a fireside chat at the conference beginning at 10:00 a.m. ET on Thursday, September 5, 2024. A live audio webcast of the presentation will be available at the Investor Relations section of the Company’s website, at https://ir.ardenthealth.com, and a replay will be available for 90 days using the same link.
In conjunction with the conference, the Ardent Health management team will be available to participate in one-on-one meetings with investors registered to attend the conference. Interested investors should contact their Morgan Stanley representative to schedule meetings.
About Ardent Health
Ardent Health (NYSE: ARDT) is a leading provider of healthcare in growing mid-sized urban communities across the U.S. With a focus on people and investments in innovative services and technologies, Ardent is passionate about making healthcare better and easier to access. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and more than 200 sites of care with over 1,700 affiliated providers across six states. For more information, please visit www.ardenthealth.com.
Last Trade: | US$11.78 |
Daily Change: | -0.33 -2.73 |
Daily Volume: | 241,898 |
Market Cap: | US$1.680B |
March 31, 2025 February 26, 2025 November 06, 2024 |
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in clinical development...
CLICK TO LEARN MOREClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...
CLICK TO LEARN MOREEnd of content
No more pages to load